Cetera Investment Advisers
IDYA icon

Cetera Investment Advisers’s IDEAYA Biosciences IDYA Stock Holding History

Cetera Investment Advisers’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$629K Sell
18,863
-5,760
-23% -$193K ﹤0.01% 3305
2025
Q4 		$851K Buy
24,623
+3,719
+18% +$119K ﹤0.01% 2968
2025
Q3 		$569K Buy
+20,904
New +$506K ﹤0.01% 3274

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cetera Investment Advisers's IDYA Position: Q1 2026 in Review

Cetera Investment Advisers reduced its IDEAYA Biosciences (IDYA) stake by 23% in Q1 2026, selling an estimated $193K and leaving 18,863 shares worth $629K. The position accounts for ﹤0.01% of the portfolio, ranked #3305.

Cetera Investment Advisers first reported a position in IDYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $851K in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Cetera Investment Advisers held 18,863 shares of IDEAYA Biosciences worth $629K as of Q1 2026.
  • Cetera Investment Advisers sold 5,760 IDEAYA Biosciences shares in Q1 2026, an estimated $193K.
  • IDEAYA Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3305 holding.
  • Cetera Investment Advisers first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's IDEAYA Biosciences position peaked at $851K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.